The Big Business Behind Weight Loss Drugs

  • Af
  • Episode
      432
  • Published
      6. feb. 2024
  • Forlag
0 Anmeldelser
0
Episode
432 of 535
Længde
32M
Sprog
Engelsk
Format
Kategori
Personlig udvikling

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications. Learn more about your ad choices. Visit podcastchoices.com/adchoices


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036

Other podcasts you might like ...